Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

975 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Mycophenolate plus methylprednisolone versus methylprednisolone alone in active, moderate-to-severe Graves' orbitopathy (MINGO): a randomised, observer-masked, multicentre trial.
Kahaly GJ, Riedl M, König J, Pitz S, Ponto K, Diana T, Kampmann E, Kolbe E, Eckstein A, Moeller LC, Führer D, Salvi M, Curro N, Campi I, Covelli D, Leo M, Marinò M, Menconi F, Marcocci C, Bartalena L, Perros P, Wiersinga WM; European Group on Graves' Orbitopathy (EUGOGO). Kahaly GJ, et al. Among authors: leo m. Lancet Diabetes Endocrinol. 2018 Apr;6(4):287-298. doi: 10.1016/S2213-8587(18)30020-2. Epub 2018 Jan 31. Lancet Diabetes Endocrinol. 2018. PMID: 29396246 Clinical Trial.
Asymmetry indicates more severe and active disease in Graves' orbitopathy: results from a prospective cross-sectional multicentre study.
Perros P, Žarković MP, Panagiotou GC, Azzolini C, Ayvaz G, Baldeschi L, Bartalena L, Boschi AM, Nardi M, Brix TH, Covelli D, Daumerie C, Eckstein AK, Fichter N, Ćirić S, Hegedüs L, Kahaly GJ, Konuk O, Lareida JJ, Okosieme OE, Leo M, Mathiopoulou L, Clarke L, Menconi F, Morris DS, Orgiazzi J, Pitz S, Salvi M, Muller I, Knežević M, Wiersinga WM, Currò N, Dayan CM, Marcocci C, Marinò M, Möller L, Pearce SH, Törüner F, Bernard M; European Group on Graves’ Orbitopathy. Perros P, et al. Among authors: leo m. J Endocrinol Invest. 2020 Dec;43(12):1717-1722. doi: 10.1007/s40618-020-01258-w. Epub 2020 May 30. J Endocrinol Invest. 2020. PMID: 32474767 Free PMC article.
Selenium in Graves Hyperthyroidism and Orbitopathy.
Marinò M, Menconi F, Rotondo Dottore G, Leo M, Marcocci C. Marinò M, et al. Among authors: leo m. Ophthalmic Plast Reconstr Surg. 2018 Jul/Aug;34(4S Suppl 1):S105-S110. doi: 10.1097/IOP.0000000000001136. Ophthalmic Plast Reconstr Surg. 2018. PMID: 29933354 Review.
Treatment options for Graves' orbitopathy.
Marcocci C, Altea MA, Leo M. Marcocci C, et al. Among authors: leo m. Expert Opin Pharmacother. 2012 Apr;13(6):795-806. doi: 10.1517/14656566.2012.668529. Epub 2012 Mar 9. Expert Opin Pharmacother. 2012. PMID: 22404364 Review.
Thyroid volume and severity of Graves' orbitopathy.
Profilo MA, Sisti E, Marcocci C, Vitti P, Pinchera A, Nardi M, Rocchi R, Latrofa F, Menconi F, Altea MA, Leo M, Rago T, Marinò M. Profilo MA, et al. Among authors: leo m. Thyroid. 2013 Jan;23(1):97-102. doi: 10.1089/thy.2012.0379. Thyroid. 2013. PMID: 23088654
975 results